BFC Planning’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
BFC Planning's IMCR Position: Q2 2026 in Review
BFC Planning sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 81 shares — an estimated $2.44K sold.
BFC Planning first reported a position in IMCR in Q3 2024 and held it in 7 quarters. The position peaked at $2.94K in Q3 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.
- BFC Planning reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
- BFC Planning sold 81 Immunocore shares in Q2 2026, an estimated $2.44K.
- BFC Planning first reported a position in Immunocore in Q3 2024 and held it in 7 quarters.
- BFC Planning's Immunocore position peaked at $2.94K in Q3 2025.
- 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.
Based on BFC Planning's 13F filing for Q2 2026, filed 29 Oct 2026.